최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of hematology, v.77 no.4, 2003년, pp.371 - 375
Seriu, Taku , Stark, Yvonne , Erz, Dorothee , Bartram, Claus R.
We characterized 168 junctional regions of T-cell receptor delta (TCRD) rearrangements from 116 children with acute lymphoblastic leukemia (ALL) (101 with precursor B-cell ALL, 15 with T-cell ALL). Application of 101 allele-specific oligonucleotide (ASO) probes representing 85 Vdelta2Ddelta3, 10 Dde...
N Engl J Med. H Cave 339 591 1998 10.1056/NEJM199808273390904 Cave H, van der Werfften Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia.N Engl J Med. 1998;339:591-598.
Lancet. JJM Dongen van 352 1731 1998 10.1016/S0140-6736(98)04058-6 van Dongen JJM, Seriu T, Panzer-Grümayer ER, et al. Prognostic value on minimal residual disease in acute lymphoblastic leukaemia in childhood.Lancet. 1998;352:1731-1738.
Blood. MJ Willemse 99 4386 2002 10.1182/blood.V99.12.4386 Willemse MJ, Seriu T, Hettinger K, et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.Blood. 2002;99:4386-4393.
Leukemia. MJ Pongers-Willemse 13 110 1999 10.1038/sj.leu.2401245 Pongers-Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets.Leukemia. 1999;13:110-118.
Leukemia. MJ Pongers-Willemse 12 2006 1998 10.1038/sj.leu.2401246 Pongers-Willemse MJ, Verhagen OJHM, Tibbe GJM, et al. Realtime quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.Leukemia. 1998;12:2006-2014.
Cancer Res. M Nakao 60 3281 2000 Nakao M, Janssen JWG, Flohr T, Bartram CR. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.Cancer Res. 2000;60:3281-3289.
Leukemia. C Guidal 16 762 2002 10.1038/sj.leu.2402396 Guidal C, Vilmer E, Grandchamp B, et al. A competitive PCRbased method usingTCRD, TCRG andIGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.Leukemia. 2002;16:762-764.
Blood. TM Breit 82 3063 1993 10.1182/blood.V82.10.3063.3063 Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoven MAJ, van Wering ER, van Dongen JJM. Southern blot patterns, frequencies and junctional diversity of T-cell receptor-δ gene rearrangements in acute lymphoblastic leukemia.Blood. 1993;82:3063-3074.
Leukemia. T Szczepanski 13 196 1999 10.1038/sj.leu.2401277 Szczepanski T, Beishuizen A, Pongers-Willemse MJ, et al. Crosslineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.Leukemia. 1999;13:196-205.
Leukemia. TM Breit 5 1076 1991 Breit TM, Wolvers-Tettero ILM, Hählen K, van Wering ER, van Dongen JJM. Extensive junctional diversity of γ δ T-cell receptors expressed by T-cell acute lymphoblastic leukemia: implications for the detection of minimal residual disease.Leukemia. 1991;5:1076-1086.
Med Pediatr Oncol. A Berg van der Does-van den 20 497 1992 10.1002/mpo.2950200603 van der Does-van den Berg A, Bartram CR, Basso G, et al. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” cooperative group.Med Pediatr Oncol. 1992;20:497-505.
Blood. S Yokota 77 331 1991 10.1182/blood.V77.2.331.331 Yokota S, Hansen-Hagge TE, Ludwig WD, et al. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.Blood. 1991;77:331-339.
Leukemia. T Seriu 9 316 1995 Seriu T, Hansen-Hagge TE, Erz DHR, Bartram CR. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.Leukemia. 1995;9:316-320.
Leukemia. T Seriu 11 759 1997 10.1038/sj.leu.2400643 Seriu T, Erz D, Stark Y, Bartram CR. T-cell receptor Dδ2Dδ3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.Leukemia. 1997;11:759-761.
Blood. TE Hansen-Hagge 85 1888 1995 10.1182/blood.V85.7.1888.bloodjournal8571888 Hansen-Hagge TE, Mahotka C, Panzer-Grümayer RE, et al. Alternative splicing restricts translation of rearrangements at the T-cell receptor δ/ α locus.Blood. 1995;85:1888-1896.
EMBO J. SM Lewis 10 3631 1991 10.1002/j.1460-2075.1991.tb04929.x Lewis SM, Hesse JE. Cutting and closing without recombination in V(D)J joining.EMBO J. 1991;10:3631-3639.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.